# Significance of Regional Ventriculo-arterial Coupling in Patients With Chronic Heart Failure

Study · id `cardio:ct-nct01156207` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT01156207](<https://clinicaltrials.gov/study/NCT01156207>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT01156207

Browse, organ or system: Heart  
Browse, condition area: Heart failure  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 120 participants.

## Technical summary

Registry record NCT01156207. Randomized; triple masking; primary purpose treatment. Start 2010-07 (registry gives no type); primary completion 2013-07 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; triple masking; primary purpose treatment
- Phase: Phase 4
- Enrolled: 120 participants (planned count; ClinicalTrials.gov record NCT01156207, source copy `cardio:ctgov-nct01156207-2010-07-02`, retrieved 2026-10-26)
- Start date: 2010-07 (registry gives no type) (ClinicalTrials.gov record NCT01156207, source copy `cardio:ctgov-nct01156207-2010-07-02`, retrieved 2026-10-26)
- Primary completion: 2013-07 (anticipated) (ClinicalTrials.gov record NCT01156207, source copy `cardio:ctgov-nct01156207-2010-07-02`, retrieved 2026-10-26)
- Completion: Not reported
- Countries: Taiwan (ClinicalTrials.gov record NCT01156207, source copy `cardio:ctgov-nct01156207-2010-07-02`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "UNKNOWN" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct01156207-2010-07-02`, retrieved 2026-10-26)

## The registry's words

- Brief title: Significance of Regional Ventriculo-arterial Coupling in Patients With Chronic Heart Failure
- Acronym: VACHF
- Condition: Heart Failure
- Intervention (Drug): Aliskiren
- Lead sponsor: Taipei Veterans General Hospital, Taiwan
- Lead sponsor class: OTHER\_GOV
- Collaborator: National Science and Technology Council, Taiwan
- Collaborator class: OTHER\_GOV

## Connected pages

- Registry condition terms include this condition: Heart failure (`cardio:heart-failure`)
- Registry lists this organization as the lead sponsor: Taipei Veterans General Hospital, Taiwan (`cardio:org-taipei-veterans-general-hospital-taiwan`)

## Provenance

Content hash: 9e3f26b6320989af68f968332c6d517c419dcdc4151b767027ababb7d5f1ed4a
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
